Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Discordant Hormonal Status Between Primary Tumor and Axillary Lymph Node in Breast Cancer Patients.

NCT01943032 is registered in ClinicalTrials.gov with National Cancer Institute, Thailand as lead sponsor.

NCT NCT01943032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01943032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Discordant Hormonal Status Between Primary Tumor and Axillary Lymph Node in Breast Cancer Patients.
Lead sponsor
National Cancer Institute, Thailand
Phase
Observational
Overall status
Completed
Start date
April 30, 2011
Completion date
April 30, 2012
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant neoplasm of breast.